Actions

Theodore A. Litovitz

From Kook Science

Theodore A. Litovitz
Born 14 October 1923(1923-10-14)
New York
Died 1 May 2006 (82) [1]
Annapolis, Anne Arundel Co., Maryland
Alma mater George Washington University; Catholic University of America (Ph.D.)
Workplace(s) Catholic University of America

Theodore Aaron Litovitz (October 14, 1923 - May 1, 2006) was an American physicist who developed technologies in the areas of fibre optics and electromagnetics, in particular having patented technologies intended to protect against health effects he proposed could be caused by exposure to electro-magnetic fields,[1] as well as methods of using vitrification for radioactive waste storage.

Selected Patents

  • US5450859A. Protection of living systems from adverse effects of electric, magnetic and electromagnetic fields. 19 Sept. 1995, filed 6 July 1993. Assigned to Catholic University of America. "The disclosed embodiments of the inventions disclosed in this application develop a 'protection' electric, magnetic or electromagnetic field or fields which are either superimposed upon an ambient field which is detrimental to the health of living systems, or is incorporated into the electrical circuit of the device which is generating the detrimental field. Either arrangement is successful in 'confusing' living cells, and thereby reducing the harmful effects of the otherwise detrimental field." https://patents.google.com/patent/US5450859
  • US5968527A. Protection of living systems from the adverse effects of stress. 19 Oct. 1999, filed 4 Dec. 1997. Assigned to Catholic University of America. "Methods and apparatus are described to inhibit the adverse health effects of ischemia, hypoxia, anoxia or other stress by the application of a time-varying field to the region of the affected organ(s) for a short period of time (of the order of 20 minutes). A 'field' means a time varying electric field, a time varying magnetic field and/or a radiating electromagnetic field. The exposure can be started up to two or more hours in advance of the ischemic event or other stress causing event. Inhibition occurs even if the field is applied after the onset of ischemic or anoxic stress." https://patents.google.com/patent/US5968527A

References